Boditech Med Inc.
Research Boditech Med Inc. (206640.KQ) on Bullrun: market cap KRW 194.74B, dividend yield 1.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker206640.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 194.74B
- Dividend yield1.6%
- Financial periodQ2 2026
- RevenueKRW 50.42B
- Net incomeKRW 7.30B
- Free cash flow-KRW 2.86B
- Gross margin58.6%
Valuation Snapshot
latest market cap is KRW 194.74B; dividend yield is 1.6%.
Peer valuation comparison
Latest dividend yield is 1.64% versus a Healthcare sector median of 2.4% (31.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 194.74B | n/a | 1.6% | 150 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 150 KRW, yield 1.6%.
About Boditech Med Inc.
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boditech Med Inc.'s market cap?
Boditech Med Inc.'s market capitalization is KRW 194.74B.
Does Boditech Med Inc. pay a dividend?
Boditech Med Inc. has a dividend yield of 1.6%.
What does Boditech Med Inc. do?
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with.